My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

V-Mart Retail attracts buyers after opening new store
Mar 29,2017

The announcement was made during market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 69.05 points or 0.23% at 29,478.57. The S&P BSE Small-Cap index was up 30.05 points or 0.21% to 14,183.42.

More than usual volumes were witnessed on the counter. On the BSE, 61,653 shares were traded on the counter so far as against the average daily volumes of 29,745 shares in the past one quarter. The stock had hit a high of Rs 847.30 and a low of Rs 788 so far during the day. The stock had hit a record high of Rs 883.75 on 9 March 2017. The stock had hit a 52-week low of Rs 425 on 24 June 2016.

The small-cap company has equity capital of Rs 18.07 crore. Face value per share is Rs 10.

V-Mart Retail said that the store is a fashion store. With the opening of the store, the tally of stores in Bihar is 5 composite & 26 fashion stores. This takes the total number of stores to 141 stores in 121 cities across 14 states, with 37 composite stores & 104 fashion stores with a total area of around 11.95 lakhs square feet.

V-Mart Retail net profit rose 81.3% to Rs 27.21 crore on 23.2% growth in net sales to Rs 326.49 crore in Q3 December 2016 over Q3 December 2015.

V-Mart Retail is a hypermarket format retail chain based in New Delhi. It is a multi-brand family retail store offering apparels, general merchandise and kirana.

Powered by Capital Market - Live News

Panacea Biotec launches EasySix vaccine
Mar 29,2017

Panacea Biotec announced the launch of Worlds first fully liquid whole cell Pertussis (wP) based Hexavalent Combination Vaccine, EasySix, a vaccine researched, development and manufactured by Panacea Biotec in India.

EasySix is indicated for primary immunization to protect newborn babies against six common preventable diseases viz, Diphtheria, Tetanus, Whooping Cough, Meningitis (due to H. Influenza type b), Hepatitus B and Polio.

Powered by Capital Market - Live News

Volumes jump at Hathway Cable & Datacom counter
Mar 29,2017

Hathway Cable & Datacom clocked volume of 2.57 crore shares by 14:46 IST on BSE, a 912.92-times surge over two-week average daily volume of 28,000 shares. The stock rose 1.06% at Rs 38.05.

Astral Poly Technik notched up volume of 1.44 crore shares, a 533.07-fold surge over two-week average daily volume of 27,000 shares. The stock was down 0.29% at Rs 567.65.

Cupid saw volume of 42.61 lakh shares, a 352.97-fold surge over two-week average daily volume of 12,000 shares. The stock fell 3.43% at Rs 325.50.

Godawari Power & Ispat clocked volume of 35.29 lakh shares, a 109.59-fold surge over two-week average daily volume of 32,000 shares. The stock was up 1.73% at Rs 102.85.

Amrapali Capital and Finance Services saw volume of 51.26 lakh shares, a 105.30-fold rise over two-week average daily volume of 49,000 shares. The stock surged 4.87% at Rs 68.95.

Powered by Capital Market - Live News

Panacea Biotec in pink of health after launching vaccine
Mar 29,2017

The announcement was made during market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 105.96 points, or 0.36% to 29,515.48. The S&P BSE Small-Cap index was up 60.44 points or 0.43% to 14,213.81.

On the BSE, 39,933 shares were traded in the counter so far, compared with average daily volumes of 47,302 shares in the past one quarter. The stock had hit a high of Rs 167.80 and a low of Rs 153.05 so far during the day. The stock had hit a 52-week high of Rs 178.30 on 27 January 2017. The stock had hit a 52-week low of Rs 85.50 on 26 May 2016.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Re 1.

Panacea Biotec said the vaccine was researched, developed and manufactured by the company in India. EasySix is indicated for primary immunization to protect newborn babies against six preventive diseases namely, Diptheria, Tetanus, Whopping Cough, Hepatitis B and Polio.

Panacea Biotec reported net loss of Rs 29.25 crore in Q3 December 2016, higher than net loss of Rs 17.38 crore in Q3 December 2015. Net sales declined 34% to Rs 99.33 crore in Q3 December 2016 over Q3 December 2015.

Panacea Biotec is one of Indias leading research based biotechnology companies with established research, manufacturing and marketing capabilities.

Powered by Capital Market - Live News

Siemens and Sumitomo Electric Industries consortium wins order from PGCIL
Mar 29,2017

A consortium of Siemens and Sumitomo Electric Industries has been awarded an order from Power Grid Corporation of India, the central transmission utility of India, to supply a high-voltage direct current (HVDC) transmission system. The total size of the order won by the consortium is US $520 million, of which the share of Siemens is approximately Rs 1,682 crore.

Powered by Capital Market - Live News

Board of CHD Chemicals allots equity shares on conversion of warrants
Mar 29,2017

CHD Chemicals announced that the Board of Directors of the Company at its meeting held on 29 March 2017 has made the allotment of 12.45 lakh equity shares at an issue price of Rs 10 each on conversion of warrants. With this allotment, the paid up equity share capital has increased to Rs 6.45 crore comprising of 6454080 equity shares of Rs 10 each.

Powered by Capital Market - Live News

Talwalkars Better Value Fitness provides business update
Mar 29,2017

Talwalkars Better Value Fitness announced the opening of 10 Zorba - Renaissance studios.

Powered by Capital Market - Live News

Power Grid Corporation of India to establish transmission system in Eastern Region
Mar 29,2017

Power Grid Corporation of India has on 28 March 2017 acquired Medinipur-Jeerat Transmission, the project SPV to establish transmission system for 765kV strengthening in Eastern Region (ERSS-XVIII) on build, own, operate and maintain basis from PFC Consulting. The transmission system includes establishment of 765kV and 400kV transmission lines including establishment of two new 765/400kV substations. The transmission system is to be progressively constructed over a period of 40 months.

Powered by Capital Market - Live News

Tata Metaliks announces cessation of director
Mar 29,2017

Tata Metaliks announced that Ashok K Basu has retired as Independent Director on the Board of the Company on 23 March 2017.

Powered by Capital Market - Live News

UCO Bank nudges higher on capital raising plans
Mar 29,2017

The issue is a private placement of unsecured redeemable non-convertible fully paid up Basel III compliant tier II bonds in the nature of debentures.

The announcement was made during market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 88.02 points, or 0.3% to 29,497.54. The S&P BSE Mid-Cap index was up 39.80 points or 0.29% to 13,951.45.

On the BSE, 76,475 shares were traded in the counter so far, compared with average daily volumes of 1.44 lakh shares in the past one quarter. The stock had hit a high of Rs 36.80 and a low of Rs 36.20 so far during the day. The stock had hit a 52-week high of Rs 46.60 on 15 July 2016. The stock had hit a 52-week low of Rs 29.50 on 9 November 2016.

The mid-cap company has equity capital of Rs 1559.73 crore. Face value per share is Rs 10.

UCO Bank reported net loss of Rs 437.09 crore in Q3 December 2016 as against net loss of Rs 1497.01 crore in Q3 December 2015. Operating income declined 1.4% to Rs 4864.21 crore in Q3 December 2016 over Q3 December 2015.

The Government of India held 76.67% stake in UCO Bank as on 31 December 2016 as per the shareholding pattern.

Powered by Capital Market - Live News

Kalpataru Power Transmission secures new orders
Mar 29,2017

Kalpataru Power Transmission has secured new orders worth Rs 1200 crore.

Powered by Capital Market - Live News

IndusInd Bank partners with Lohia Auto Industries
Mar 29,2017

Lohia Auto Industries announced that IndusInd Bank would be its preferred financier for financing their electric three wheelers under the e-rickshaw category. This is in addition to the financing of diesel vehicles which the bank already provides. Through this partnership IndusInd Bank will offer retail vehicle finance at attractive rates of interest to the customers of Lohia Auto, for all Lohia 3-wheeler electronic and diesel models. This partnership will simplify the process for customers to take up three-wheeler by providing loans which are hassle free and competitively priced.

Powered by Capital Market - Live News

Board of Poly Medicure allots 4,41,13,440 bonus shares
Mar 29,2017

Poly Medicure announced that the Allotment committee of the Board of Directors of the Company, at its meeting held on 29 March 2017 has approved allotment of 4,41,13,440 fully paid Bonus Equity Shares of Rs. 5 each (Rs. Five) in the ratio of 1:1 (i.e. 1 (One) new equity bonus shares of Rs. 5 each for every 1 (one) existing fully paid equity share of Rs. 5 each held) to the members holding shares as on the Record Date i.e. 28 March 2017.

Powered by Capital Market - Live News

Loyal Equipments receives order worth Rs 1.01 crore
Mar 29,2017

Loyal Equipments has received an order worth Rs 1.01 crore from Engineers India for Ramagundam Fertilisers & Chemicals for supply of KO Drum & Inter Stage Separator.

Powered by Capital Market - Live News

Dishman Pharma extends Tuesdays sharp rally
Mar 29,2017

Meanwhile, the S&P Sensex was up 98.74 points or 0.34% at 29,508.26. The S&P BSE Mid-cap index was up 40.15 points or 0.29% at 13,951.80.

High volumes were witnessed on the counter. On the BSE, 20.19 lakh shares were traded on the counter so far as against the average daily volumes of 2.01 lakh shares in the past one quarter. The stock had hit a high of Rs 321.50 so far during the day, which is also its record high. The stock hit a low of Rs 287.95 so far during the day.

The stock had hit a 52-week low of Rs 127.60 on 24 June 2016. It had outperformed the market over the past one month till 28 March 2017, advancing 20.59% compared with the Sensexs 2.32% rise. The scrip had also outperformed the market over the past one quarter advancing 32.67% as against the Sensexs 12.2% rise.

The mid-cap company has equity capital of Rs 32.28 crore. Face value per share is Rs 2.

Shares of Dishman Pharmaceuticals & Chemicals (Dishman Pharma) have rallied 32.41% in two trading sessions from Rs 231.85 on 27 March 2017. The stock had rallied 20% to settle at Rs 278.20 yesterday, 28 March 2017 on media reports that the company has received approval from the US Food and Drug Administration (USFDA) for cancer drug Zejula Capsules.

Dish Pharma, in a clarification issued to the stock exchanges during market hours yesterday, 28 March 2017, said that the company is bound by strict confidentiality agreements with its customers and will not have any prior knowledge of the stage of development of the customers end product.

Dish Pharma further added that since it does not manufacture the innovators end product in contract research and manufacturing services (CRAMS) segment, it is Tesaro Inc., which has received the USFDA approval for cancer drug Zejula Capsules and not Dishman Pharma as mentioned in media reports.

Dishman Pharmaceuticals & Chemicals consolidated net profit rose 13.2% to Rs 50.68 crore on 7.6% decrease in net sales to Rs 356.47 crore in Q3 December 2016 over Q3 December 2015.

Dishman Pharmaceuticals & Chemicals acts as a full fledged CRAMS (contract research and manufacturing services) partner for global pharma innovators. It also makes phase transfer catalysts, Vitamin D, Vitamin D analogues, cholesterol, laolin related products, antiseptic and disinfectant formulations for pharmaceutical, cosmetic and related markets. The company also makes generic active pharmaceutical ingredients (API) and intermediates for the pharmaceutical industries.

Powered by Capital Market - Live News